Analyzing Astrana Health (NASDAQ:ASTH) and Leafbuyer Technologies (OTCMKTS:LBUY)

Astrana Health (NASDAQ:ASTH) and Leafbuyer Technologies (OTCMKTS:LBUY) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Astrana Health and Leafbuyer Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0	1	1	0	2.50
Leafbuyer Technologies	0	0	0	0	N/A

Astrana Health currently has a consensus price target of $47.00, suggesting a potential upside of 20.05%. Given Astrana Health’s higher probable upside, research analysts plainly believe Astrana Health is more favorable than Leafbuyer Technologies.

Institutional and Insider Ownership

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 11.0% of Leafbuyer Technologies shares are held by institutional investors. 8.5% of Astrana Health shares are held by company insiders. Comparatively, 24.4% of Leafbuyer Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Astrana Health and Leafbuyer Technologies’ top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$1.39 billion	1.56	$60.72 million	$1.32	29.66
Leafbuyer Technologies	$5.09 million	0.49	-$580,000.00	N/A	N/A

Astrana Health has higher revenue and earnings than Leafbuyer Technologies.

Risk & Volatility

Astrana Health has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Leafbuyer Technologies has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500.

Profitability

This table compares Astrana Health and Leafbuyer Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Astrana Health	4.49%	11.52%	6.67%
Leafbuyer Technologies	-18.38%	N/A	-59.79%

Summary

Astrana Health beats Leafbuyer Technologies on 10 of the 11 factors compared between the two stocks.

About Astrana Health

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

About Leafbuyer Technologies

Leafbuyer Technologies, Inc., through its subsidiary, LB Media Group, LLC, provides online resources for cannabis deals and specials in the United States. The company was founded in 2012 and is headquartered in Greenwood Village, Colorado.